Premium
Treatment of carcinoma of the cervix with bromocriptine
Author(s) -
GUTHRIE D.
Publication year - 1982
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1982.tb05040.x
Subject(s) - bromocriptine , medicine , cervix , carcinoma , ovary , cancer , cervix carcinoma , oncology , cervical carcinoma , gynecology , cervical cancer , hormone , prolactin
Summary. Twenty‐eight patients with advanced cancer were treated with 2·5 mg of bromocriptine twice daily. One patient with carcinoma of the ovary achieved tumour stasis. Of 18 patients with carcinoma of the cervix, three achieved tumour stasis and five achieved very long remissions with a median survival of more than 6 years from the start of treatment.